-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Myriad Genetics, Raises Price Target to $6.75

Benzinga·11/05/2026 20:28:29
Listen to the news
TD Cowen analyst Kyle Boucher maintains Myriad Genetics (NASDAQ:MYGN) with a Hold and raises the price target from $4.5 to $6.75.